These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 883822)

  • 21. Clinical comparison of cefadroxil, new oral cephalosporin, and cephalexin in uncomplicated urinary tract infection.
    Bolding OT
    Urology; 1978 Sep; 12(3):321-4. PubMed ID: 360561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Laboratory and clinical studies on cefadroxil in the field of pediatrics (author's transl)].
    Hori M; Toyonaga Y; Kurosu Y; Kumagai K
    Jpn J Antibiot; 1981 Jan; 34(1):61-76. PubMed ID: 7241807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pharmacokinetic comparison of cephalexin and cefadroxil using HPLC assay procedures.
    Welling PG; Selen A; Pearson JG; Kwok F; Rogge MC; Ifan A; Marrero D; Craig WA; Johnson CA
    Biopharm Drug Dispos; 1985; 6(2):147-57. PubMed ID: 4005394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Critical Review of Cephalexin and Cefadroxil for the Treatment of Acute Uncomplicated Lower Urinary Tract Infection in the Era of "Bad Bugs, Few Drugs".
    Nguyen HM; Graber CJ
    Int J Antimicrob Agents; 2020 Oct; 56(4):106085. PubMed ID: 32659466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative pharmacology of cefaclor and cephalexin.
    Korzeniowski OM; Scheld WM; Sande MA
    Antimicrob Agents Chemother; 1977 Aug; 12(2):157-62. PubMed ID: 900915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of cefadroxil, cephalexin, cefatrizine and cefpirome in presence of essential and trace elements.
    Sultana N; Arayne MS
    Pak J Pharm Sci; 2007 Oct; 20(4):305-10. PubMed ID: 17604254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacokinetics of cefadroxil in rats: comparison of fasting and non-fasting (author's transl)].
    Nakanomyo H; Imai K; Hiraoka M; Hasegawa Y
    Jpn J Antibiot; 1980 Aug; 33(8):778-81. PubMed ID: 7206224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose-dependent absorption and elimination of cefadroxil in man.
    Garrigues TM; Martin U; Peris-Ribera JE; Prescott LF
    Eur J Clin Pharmacol; 1991; 41(2):179-83. PubMed ID: 1743250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibacterial activity of cefamandole, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cephalexin.
    Eykyn S; Jenkins C; King A; Phillips I
    Antimicrob Agents Chemother; 1973 Jun; 3(6):657-61. PubMed ID: 4790616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Fundamental and clinical studies on cefadroxil dry syrup in children (author's transl)].
    Kobayashi Y; Morikawa Y; Haruta T; Fujiwara T
    Jpn J Antibiot; 1981 Jan; 34(1):33-40. PubMed ID: 7241805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3-Deacetoxy-7-(alpha-amino-1-cyclohexenylacetamido) cephalosporanic acid (SCE-100), a new semisynthetic cephalosporin. III. Comparative studies on absorption, distribution and excretion of SCE-100 and cephalexin (CEX) in laboratory animals.
    Yamazaki T; Tsuchiya K
    J Antibiot (Tokyo); 1976 May; 29(5):571-8. PubMed ID: 956046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of dose on the pharmacokinetics of cefadroxil.
    Mariño EL; Dominguez-Gil A
    Eur J Clin Pharmacol; 1980 Nov; 18(6):505-9. PubMed ID: 7461017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Bacteriological study on cefadroxil in vitro. Correlation between diameter of inhibition zone and inhibitory concentration (author's transl)].
    Grimm H
    Arzneimittelforschung; 1980; 30(2):301-3. PubMed ID: 6821594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative evaluation of cefadroxil and cephalexin in children and adolescents with pyodermas. Cefadroxil Once Daily Pyoderma Study Group.
    Linder CW; Nelson K; Paryani S; Stallworth JR; Blumer JL
    Clin Ther; 1993; 15(1):46-56. PubMed ID: 8458054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BMY 28100, a new oral cephalosporin.
    Leitner F; Pursiano TA; Buck RE; Tsai YH; Chisholm DR; Misiek M; Desiderio JV; Kessler RE
    Antimicrob Agents Chemother; 1987 Feb; 31(2):238-43. PubMed ID: 3105449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of food on absorption of cefadroxil and cephalexin in dogs.
    Campbell BG; Rosin E
    J Vet Pharmacol Ther; 1998 Oct; 21(5):418-20. PubMed ID: 9811445
    [No Abstract]   [Full Text] [Related]  

  • 37. Tissue and fluid concentrations of cefadroxil monohydrate.
    Bernhardt LL
    J Int Med Res; 1980; 8(Suppl 1):58-63. PubMed ID: 7439507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pharmacokinetics of cefadroxil associated with probenecid.
    Mariño EL; Dominguez-Gil A
    Int J Clin Pharmacol Ther Toxicol; 1981 Nov; 19(11):506-8. PubMed ID: 6795136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro antimicrobial activity and human pharmacology of cephalexin, a new orally absorbed cephalosporin C antibiotic.
    Thornhill TS; Levison ME; Johnson WD; Kaye D
    Appl Microbiol; 1969 Mar; 17(3):457-61. PubMed ID: 4388601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of antibacterial activities of cephalosporin antibiotics: cefazolin, cephaloridine, cephalothin, and cephalexin.
    Hsieh WC; Ho SW
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1975 Mar; 8(1):1-11. PubMed ID: 1097210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.